In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use

Journal of Antibiotics

Volumn 52, Issue 11, 1999, Pages 1007-1016

  Norcia, Laura J L ^a   Silvia, Annette M ^a   Dirlam, John P ^a   Schnur, Rodney C ^a   Bergeron, Jay M ^a   Retsema, James A ^a   Hayashi, Shigeru F ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CAPREOMYCIN; CATION; CP 101 680; CP 163 234; CYCLOPEPTIDE; DRUG ANALOG; EDETIC ACID; PENTAPEPTIDE; UNCLASSIFIED DRUG; VIOMYCIN;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG BINDING; DRUG POTENCY; ESCHERICHIA COLI; MANNHEIMIA HAEMOLYTICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA MULTOCIDA; PH; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SERUM;

EID: 0032761523     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.1007     Document Type: Article

References (16)

1. HERR, E. B. Jr.; M. E. HENRY, G. E. PITTENGER & C. E. HIGGENS: Isolation and characterization of a new peptide antibiotic. Proceedings Indiana Academy of Sciences 69: 134, 1959
2. STARK, W. M. & L. D. BOECK: Biosynthesis of capreomycin I in a chemically defined medium. Antimicrobial Agents & Chemotherapy 5: 157-164, 1965
3. GOULD, S. J. & D. A. MINOTT: Biosynthesis of capreomycin. 1. Incorporation of arginine. Journal of Organic Chemistry 57: 5214-5217, 1992
4. WANG, M. & S. J. GOULD: Biosynthesis of capreomycin. 2. Incorporation of L-serine, L-alanine, and L-2,3-diaminopropionic acid. Journal of Organic Chemistry 58: 5176-5180, 1993
5. PLACE, V. A. & H. BLACK, Ed. New antituberculosis agents: Laboratory and clinical studies. Annals of the New York Academy of Science, 135, 1966
6. HAUSNER, T.-P.; U. GEIGENMULLER & K. H. NIERHAUS: The allosteric three-site model for the ribosomal elongation cycle: new insight into the inhibition mechanisms of aminoglycosides, thiostrepton, and viomycin. Journal of Biological Chemistry 263: 13103-13111, 1988
7. DIRLAM, J. P.; A. M. BELTON, N. C. BIRSNER, R. R. BROOKS, S.-P. CHANG, R. Y. CHANDRASEKARAN, J. CLANCY, B. J. CRONIN, B. P. DIRLAM, S. M. FINEGAN, S. A. FROSHAUER, A. E. GIRARD, S. F. HAYASHI, R. J. HOWE, J. C. KANE, B. J. KAMICKER, S. A. KAUFMAN, N. L. KOLOSKO, M. A. LEMAY, R. G. LINDE II, J. P. LYSSIKATOS, C. P. MACLELLKLAND, T. V. MAGGE, M. A. MASSA, S.A. MILEER, M. L. MINICH, D. A. PERRY, J. W. PETITPAS, J. P. RAINVILLE, C. P. REESE, S. B. SEIBEL, W.-G. SU, K. T. SWEENEY, D. A. WHIPPLE & B. V. YANG: Cyclic homopentapeptides 1. Analogs of tuberactiomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella. Bioorganic & Medicinal Chemistry Letters 7, 1139-1144, 1997
8. LYSSIKATOS, J. P;. S.-P. CHANG, J. CLANCY, J. P. DIRLAM, S. M. FINEGAN, A. E. GIRARD, S. F. HAYASHI, D. P. LARSON, A. S. Lee, R. G. LINDE II, C. P. MACLELLAND, J. W. PETITPAS, S. B. SEIBEL & C. B. VU: Cyclic-homopeptides 2. Synthetic modifications of viomycin. Bioorganic & Medicinal Chemistry Letters 7: 1145-1148, 1997
9. MA, D.; D. N. COOK, M. ALBERT, N. G. PON, H. NIKAIDO & J. E. HEARST: Genes acrA. and acrB encode a stress-induced efflux system of Escherichia coli. Molecular Microbiology 16: 45-55, 1995
10. ROANTTREE, R. J.; T.-T. KUO, & D. G. MACPHEE: The effect of defined lipopolysaccharide core defects upon antibiotic resistance of Salmonella typhimurium. Journal of General Microbiology 103: 223-234, 1977
11. HAYASHI, S. F.; L. J. L. NORCIA, S. B. SEIBEL & A. M. SILVIA: Structure-activity relationship of hygromycin A and its analogs: protein synthesis inhibition activity in a cell free system. J. Antibiotics 50: 555-562, 1997
12. PANKUCH, G. A.; M. R. JACOBS & P. C. APPELBAUM: Study of comparative antipneumococcal activities of penicillin, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial Agents & Chemotherapy 38: 2065-2072, 1994
13. NORCIA, L. J. L.; S. B. SEIBEL, B. J. KAMICKER, M. A. LEMAY, S. C. LILLEY, S. J. HECKER, J. M. BERGERON, J. A. RETSEMA & S. F. HAYASHI: In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. J. Antibiotics 51: 136-144, 1998
14. NORCIA, L. J. L.; A. M. SILVIA & S. F. HAYASHI: Studies on time-kill kinetics of different classes of antibiotics against veterinary pathogenic bacteria including Pasteurella, Actinobacillus and Escherichia coli. J. Antibioitcs 52: 52-60, 1999
15. CLANCY, J.; J. PETITPAS, F. DIB-HAJJ, W. YUAN, M. CRONAN, A. V. KAMATH, J. BERGEON & J. RETSEMA: Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Molecular Microbiology 22: 867-879, 1996
16. HEIFETS, L. & P. LINDHOLM-LEVY: Comparison of bactericidal activities of streptomycin, amikacin, kanamycin and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrobial Agents & Chemotherapy 33: 1298-1301, 1989